Erratum to: Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML).
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 325, doi. 10.1007/s40259-014-0093-2
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2014 AND VI 28 AND IP 3
Results: 10
1
2
The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 285, doi. 10.1007/s40259-014-0084-3
- By:
- Publication type:
- Article
3
Bacteriophage Polysaccharide Depolymerases and Biomedical Applications.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 265, doi. 10.1007/s40259-013-0081-y
- By:
- Publication type:
- Article
4
Erratum to: Bacteriophage Polysaccharide Depolymerases and Biomedical Applications.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 323, doi. 10.1007/s40259-014-0092-3
- By:
- Publication type:
- Article
5
Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 275, doi. 10.1007/s40259-013-0079-5
- By:
- Publication type:
- Article
6
Management of Relapsed or Refractory Hodgkin Lymphoma with Second-Generation Antibody-Drug Conjugates: Focus on Brentuximab Vedotin.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 245, doi. 10.1007/s40259-013-0077-7
- By:
- Publication type:
- Article
7
Attenuation of Carbon Tetrachloride-Induced Hepatic Injury with Curcumin-Loaded Solid Lipid Nanoparticles.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 297, doi. 10.1007/s40259-014-0086-1
- By:
- Publication type:
- Article
8
Calcitonin Gene-Related Peptide Targeted Immunotherapy for Migraine: Progress and Challenges in Treating Headache.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 237, doi. 10.1007/s40259-014-0083-4
- By:
- Publication type:
- Article
9
A Review of CT-P13: An Infliximab Biosimilar.
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 313, doi. 10.1007/s40259-014-0094-1
- By:
- Publication type:
- Article
10
Management of Metastatic Breast Cancer with Second-Generation Antibody-Drug Conjugates: Focus on Glembatumumab Vedotin (CDX-011, CR011-vcMMAE).
- Published in:
- BioDrugs, 2014, v. 28, n. 3, p. 253, doi. 10.1007/s40259-014-0085-2
- By:
- Publication type:
- Article